{"transactions":[{"id":1042014,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:24:29.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.29,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114659","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114659/ownership.xml","form_type":"4"}},{"id":1042013,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:24:29.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.46,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114659","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114659/ownership.xml","form_type":"4"}},{"id":1042012,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:24:29.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":16.6,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-25-114659","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114659/ownership.xml","form_type":"4"}},{"id":1042011,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:24:29.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":21,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000950170-25-114659","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114659/ownership.xml","form_type":"4"}},{"id":1042010,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T20:24:29.000Z","date":"2025-09-11","kind":"other","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"By Gail J. Maderis Revocable Trust dtd 04-08- 2013 Gail Maderis TTEE"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-114659","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114659/ownership.xml","form_type":"4"}},{"id":1042009,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T20:24:29.000Z","date":"2025-09-11","kind":"other","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-114659","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114659/ownership.xml","form_type":"4"}},{"id":1043242,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-11T13:14:20.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114131/ownership.xml","form_type":"4"}},{"id":1043241,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T13:14:20.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":true,"shares":5500,"price":1.22,"value":6710.0,"ownership":{"direct":true},"balance_after":5500,"source":{"system":"sec-edgar","filing":"0000950170-25-114131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114131/ownership.xml","form_type":"4"}},{"id":1398667,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-27T16:18:21.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date."}],"balance_after":5500,"derivative":{"exercise_price":1.22,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-110020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017024110020/ownership.xml","form_type":"4"}},{"id":1845635,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T17:32:30.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 21, 2023 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":5500,"derivative":{"exercise_price":5.29,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-23-039473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919123039473/doc4.xml","form_type":"4"}},{"id":2187304,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-12T20:08:55.000Z","date":"2022-08-12","kind":"purchase","acquired":true,"shares":25204,"price":0.7139,"value":17993.1356,"ownership":{"direct":false,"nature":"By Gail J. Maderis Revocable Trust dtd 04-08- 2013 Gail Maderis TTEE"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.6901 to $0.7763 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001209191-22-045706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122045706/doc4.xml","form_type":"4"}},{"id":2188416,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:28:52.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":24796,"price":0.6986,"value":17322.4856,"ownership":{"direct":false,"nature":"By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.69 to $0.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":174796,"source":{"system":"sec-edgar","filing":"0001209191-22-045511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122045511/doc4.xml","form_type":"4"}},{"id":2188415,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:28:52.000Z","date":"2022-08-10","kind":"purchase","acquired":true,"shares":79693,"price":0.6859,"value":54661.4287,"ownership":{"direct":false,"nature":"By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.6726 to $0.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-22-045511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122045511/doc4.xml","form_type":"4"}},{"id":2188414,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:28:52.000Z","date":"2022-08-09","kind":"purchase","acquired":true,"shares":70307,"price":0.6423,"value":45158.1861,"ownership":{"direct":false,"nature":"By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.6103 to $0.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":70307,"source":{"system":"sec-edgar","filing":"0001209191-22-045511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122045511/doc4.xml","form_type":"4"}},{"id":2228642,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T16:11:31.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 15, 2022 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":55000,"derivative":{"exercise_price":0.5463,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-22-037835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122037835/doc4.xml","form_type":"4"}},{"id":2666899,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T16:34:35.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 15, 2021 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":27500,"derivative":{"exercise_price":1.66,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-21-040928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919121040928/doc4.xml","form_type":"4"}},{"id":2922288,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-05T19:01:52.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in installments of one-third of the total number of shares granted on each anniversary of the grant date."}],"balance_after":70000,"derivative":{"exercise_price":2.1,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-21-001606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919121001606/doc4.xml","form_type":"4"}},{"id":3387047,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2019-10-28T20:25:58.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 12 equal monthly installments beginning on the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.3,"exercise_date":"2019-05-30","expiration_date":"2029-05-30","underlying":"Common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-19-020740","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774919020740/rdgdoc.xml","form_type":"4"}},{"id":3907828,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T20:18:26.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"stock options will vest in 12 equal monthly installments."}],"balance_after":84213,"derivative":{"exercise_price":2.2,"exercise_date":"2018-06-30","expiration_date":"2028-05-31","underlying":"common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-18-011211","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774918011211/rdgdoc.xml","form_type":"4"}},{"id":4501642,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true}}],"security":"stock option (right to buy)","published_at":"2017-01-04T23:07:42.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":23883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the 2007 Omnibus Incentive Plan and the 2017 NonEmployee\nDirector Compensation Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options will vest in equal monthly installments over one year starting from the date of grant"}],"balance_after":59769,"derivative":{"exercise_price":3.24,"exercise_date":"2017-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":23883},"source":{"system":"sec-edgar","filing":"0001437749-17-000190","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774917000190/rdgdoc.xml","form_type":"4"}},{"id":4587792,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":75469,"kind":"person","name":"Maderis Gail J","position":1,"cik":"0001503147","reported_name":"Maderis Gail J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-10-04T08:01:12.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":6455,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25884,"source":{"system":"sec-edgar","filing":"0001354488-16-008338","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000135448816008338/issuerdirect_section16.xml","form_type":"4"}}]}